Related Experiment Video
Updated: May 5, 2026

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes
Published on: November 1, 2011
A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell
Gilles Courtois1, Asma Smahi, Janine Reichenbach
1Unité de Biologie Moléculaire de l'Expression Génique, Centre National de la Recherche Scientifique URA 2582, Institut Pasteur, Paris, France.
A novel autosomal-dominant form of anhidrotic ectodermal dysplasia with immunodeficiency (AD-EDA-ID) results from a mutation in IkappaBalpha, impairing NF-kappaB signaling and causing unique T cell defects.
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- X-linked anhidrotic ectodermal dysplasia with immunodeficiency (XL-EDA-ID) is linked to NEMO/IKKgamma gene mutations affecting NF-kappaB pathway.
- The NF-kappaB pathway is crucial for immune responses and cellular development, regulating gene expression via IKK and IkappaBalpha.
Observation:
- An autosomal-dominant (AD) form of EDA-ID was identified, caused by a specific mutation in IkappaBalpha (serine 32).
- This IkappaBalpha mutation enhances its inhibitory function, leading to impaired NF-kappaB activation.
Findings:
- Both XL-EDA-ID and the newly identified AD-EDA-ID share developmental, immunological, and infectious phenotypes, including ectodermal dysplasia and impaired responses to inflammatory signals.
- AD-EDA-ID presents a unique and severe T cell immunodeficiency, characterized by a lack of memory T cells and non-responsive naive T cells.
Implications:
- This study expands the understanding of genotype-phenotype diversity in EDA-ID.
- Mutations in different components of the NF-kappaB pathway can lead to distinct immunodeficiency profiles, highlighting the pathway's complex role in immunity.
Related Concept Videos
Cytoskeletal Linker Proteins - Plakins
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation III: Hyperplasia
Cellular Adaptation IV: Dysplasia and Metaplasia
Type I Diabetes I: Introduction

